• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Health Tip: Understanding Root Canal

drugsJuly 05, 2019

Tag: root , canal , teeth , anesthesia

Millions of teeth are treated by root canal each year, says the American Association of Endodontists. A root canal is the process of removing an injured or diseased tooth.

The procedure often is the best way to relieve serious pain and bring a tooth back to health.

Patients are given anesthesia for the procedure, so it typically is not painful. However, a root canal can be sore, numb or uncomfortable for a few days.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:How to Avoid Information Overload

Next:Health Tip: Severe Thunderstorm Safety

Related News

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Pharus Diagnostics LLC. (PharusDx), announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Health Tip: Understanding Root Canal | Pharmasources.com

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Innovent Biologics announced that China's National Medical Products Administration (NMPA) has approved a New Drug Application (NDA) of DOVBLERON ® .

You may like
More>>

Isatidis radix soft capsules (Extract of root of Isatis indigotica Fort. )

Isatidis radix soft capsules (Extract of root of Isatis indigotica Fort. )
Turmeric Root Extract 95% Curcumin

Turmeric Root Extract 95% Curcumin

Valerian Root Extract

Valerian Root Extract
Ginger Root Extract

Ginger Root Extract
Gentian Root Extract Gentiopicrin 5%

Gentian Root Extract Gentiopicrin 5%
octadecanal

octadecanal
Maca Root Extract

Maca Root Extract
Burdock Root Extract

Burdock Root Extract
Burdock Root Extract Powder

Burdock Root Extract Powder
Ashwagandha Extract and Ashwagandha Ashwagandha Root Extract

Ashwagandha Extract and Ashwagandha Ashwagandha Root Extract

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service